Biotech Week articles from March 2004

Biotech Week archives from March 2004

Adeno-associated virus encoded for factor IX ameliorates hemophilia B in vivo.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Adeno-associated virus encoded for factor IX ameliorates hemophilia B in vivo. According to recent research from the United States, "previous experiments have demonstrated the stable expression of...

Binding sites keep hepatitis C virus sensitive to non-nucleoside inhibitors.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Binding sites keep hepatitis C virus sensitive to non-nucleoside inhibitors. According to published research from the United States, "the RNA-dependent RNA polymerase of hepatitis C virus (HCV) is...

FDA approves ThermaFix process.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Edwards Lifesciences Corporation (EW) has received approval from the U.S. Food and Drug Administration (FDA) for its ThermaFix process, a proprietary advanced tissue treatment developed to mitigate...

Oral insulin study data indicate desired activity, no hypoglycemic events.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Emisphere Technologies, Inc., (EMIS) announced preliminary results from the first multiple-dose clinical study of an oral insulin tablet using its eligen technology. The 13-patient study (7...

Company announces positive results in phase I dental study.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Isolagen, Inc., (ILE), a biopharmaceutical company specializing in the development and commercialization of autologous (a patient's own) cellular therapy for hard and soft tissue regeneration (the...

Study: Lp-PLA2 predicts coronary heart disease.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- A prospective, case cohort study of the atherosclerosis risk in communities (ARIC) population supports the measurement of lipoprotein-associated phospholipase A2 (Lp-PLA2) to help identify individuals...

Method to detect glimepiride in human plasma developed.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Scientists have developed a method to determine glimepiride in human plasma using liquid chromatography-electrospray ionization tandem mass spectrometry. "A sensitive and specific high-performance...

McBride named senior VP of business development at biotech firm.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- AGY Therapeutics, Inc., announced the appointment of Timothy McBride as senior vice president of business development. In his new position McBride will be responsible for strategic partnering...

Nigerian AIDS sufferers complain that shortages and corruption threaten lives.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- A Nigerian government program to provide cheap medicine for people infected with HIV has run out of supplies, jeopardizing more than 14,000 who began taking the drugs 2 years ago, AIDS activists say....

Breast-fed infants of mothers who smoke incur iodine deficiency.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Breast-fed infants of mothers who smoke incur iodine deficiency. According to recent research published in the Journal of Clinical Endocrinology and Metabolism, "lack of iodine for thyroid hormone...

Plasma macrophage-derived soluble CD163 is increased in Gaucher disease.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher disease. According to a study from Denmark and the Netherlands, "Recently,...

Linda Manoogian Fingerle named to board of directors.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced that Linda Manoogian Fingerle was appointed to the company's board of directors. Fingerle brings extensive business management and financial planning...

FDA provides marketing clearance for magnesium assay.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced that it has received U.S. Food and Drug Administration (FDA) market clearance for its...

Phase III trial initiated to explore use of Humira.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced the initiation of a global phase III study evaluating the potential of Humira (adalimumab) in treating ankylosing spondylitis. Ankylosing spondylitis (AS), or...

Prosecutors investigating December price hike on AIDS medicine.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Investigators in Illinois and New York are trying to determine if Abbott Laboratories broke the law when it increased the cost of a commonly used AIDS medicine. Attorney General Lisa Madigan's...

Phase I study of ABX-PTH initiated.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Abgenix, Inc., (ABGX) announced that the company has started a phase I clinical trial of ABX-PTH, a fully human monoclonal antibody generated by Abgenix's technology platform that targets and...

Nanotechnology leader named to scientific advisory board at biochip company.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Acacia Research Corporation (CBMX)(ACTG) announced that its CombiMatrix group has named F. Mark Modzelewski to its scientific advisory board. Modzelewski is the founder and executive director of the...

Group takes issue with "formulary" provision in discount drug card regulation.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- The Academy of Managed Care Pharmacy (AMCP) submitted comments to the Centers for Medicare and Medicaid (CMS) expressing concern over several of the provisions in the interim final rule for CMS's...

Biopharmaceutical company receives $5M equity investment.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- PPD, Inc., (PPDI) has made a $5 million equity investment in Accentia, Inc. Under the terms of the agreements, PPD purchased shares of Accentia's Series E convertible preferred stock. In addition to...

Update provided on Polymer Platinate AP5346 program.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) provided an update on the status of its AP5346 Polymer Platinate Program, including the patent status, preclinical data, and the progress of the phase I clinical...

Americans find prescription drug advertising helpful, survey shows.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Direct-to-consumer (DTC) advertising for prescription drugs is impacting the healthcare decisions of American consumers, according to a survey by Advanced Analytics Inc., a custom market research firm....

Cachexia drug developer secures $12M in financing.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that it entered into an agreement with James Dicke II and his son James Dicke III whereby ADVR shall sell to the two purchasers an aggregate of 120,000,000...

Patent granted for EradicAide technology to diagnose, prevent, treat AIDS.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Adventrx Pharmaceuticals (AVRX) announced that its collaborators at the University of Texas M.D. Anderson Cancer Center have been issued United States Patent number 6,656,471 entitled "HIV-specific...

Gates Foundation commits $82.9 million to develop new tuberculosis vaccines.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- The Bill & Melinda Gates Foundation has announced an $82.9 million grant to the Aeras Global TB Vaccine Foundation to support development of new vaccines to prevent tuberculosis (TB), a disease that...

Company introduces new long-term care insurance options.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Aetna (NYSE: AET) Group Insurance has added two more major enhancements to its portfolio of group long-term care products - a core-and-buy-up plan for small to mid-sized employers and enhanced informal...

Insurer awards grants to help reduce healthcare disparities in Hartford.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Aetna (NYSE: AET) has awarded $100,000 in grants to promote cultural competency education and preventive health programs aimed at reducing the disparities in healthcare that exist among Hartford,...

Whole human genome microarray launched.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Agilent Technologies, Inc., (A) announced commercialization of its whole human genome microarray compatible with major 1" x 3" microarray scanners. The microarray provides the same industry-leading...

Elevated LVEDP may induce myocardial cytokine release.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Elevated LVEDP may induce myocardial cytokine release in heart failure patients. According to recent research from South Korea, "Proinflammatory cytokines and their receptors are increased in the...

Ras activation causes endothelial cells to acquire an angiogenic phenotype.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Ras activation causes endothelial cells to acquire an angiogenic phenotype. "Angiogenic factors alter endothelial cell phenotype to promote the formation of new blood vessels, a process critical for...

Depression may be a risk factor for heart disease, death in older women.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Older women with symptoms of depression may be at an increased risk of heart disease and death, researchers suggest. Previous studies report that depressive symptoms, including sub-threshold...

Unnecessary hospital stay after heart attack common in European countries.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Despite a decade of research suggesting that low-risk patients can be discharged from the hospital after 4 days, many countries - especially in Europe - could be keeping patients in hospital for an...

Results of Eculizumab trial reported.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced the publication of its eculizumab clinical trial results in patients with paroxysmal nocturnal hemoglobinuria (PNH) in The New England Journal of...

Oncology company raises $1.5M in private placement of common stock.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Alfacell Corporation (ACEL) announced the completion of a private placement of common stock and common stock purchase warrants with an institutional investor that raised $1.5 million in gross proceeds...

Bronchial washings are not reliable in diagnosing carcinoid lung tumors.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Bronchial washings can have false-negative results, researchers say. "Bronchial washings are used routinely in the diagnosis of lung tumors. However, unlike other tumors, the diagnosis of bronchial...

Botulinum toxin type A highly effective treatment for excessive sweating.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Results of a phase III clinical study using botulinum toxin type A to treat primary axillary hyperhidrosis, or excessive underarm sweating, show that botulinum toxin type A is safe and effective for...

FDA accepts NDA with priority review for RSR13.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that the Division of Oncology Drug Products at the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA)...

Co-brand partnership agreement signed with 3M.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Alltracel Pharmaceuticals, plc, (AP.L) announced a material supply, technology transfer and co-brand partnership program with the Health Care division of 3M (MMM), the global diversified technology...

FDA urged to crack down on Internet sales of isotretinoin.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- In a letter sent to the U.S. Food and Drug Administration (FDA), the American Academy of Dermatology Association (AADA) called on the FDA to halt Internet sales of isotretinoin, commonly known as...

AHA issues new guidelines for preventing heart disease in women.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- The American Heart Association (AHA) recently announced new guidelines for the prevention of cardiovascular disease (CVD) in women. Published in the February 2004 issue of Circulation, an AHA...

Latest imaging solution designed to simplify 2-D gel analysis.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Newly updated 2-D electrophoresis gel image analysis software available from Amersham Biosciences, the life sciences company of Amersham (AHM), is designed to help address critical bottlenecks of image...

Device firm names biosciences executive Jack Ball as first CEO.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Jack T. Ball, Jr., a seasoned professional with a strong background in the biosciences tools and reagents markets, has been named chief executive officer of Amnis Corporation. Ball, 56, succeeds...

Rice named CEO at pharmaceutical firm.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) announced that Thomas P. Rice has been elected as the company's CEO, effective immediately. Lane has also resigned from the company's board of directors. Rice succeeds Richard...

FDA approves Orthovisc; Anika to receive $20M milestone payment.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Anika Therapeutics, Inc., (ANIK) announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for Orthovisc, a highly purified, high molecular weight form of...

Recombinant G-CSF can activate tissue factor pathway.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- The use of rhG-CSF for stem-cell mobilization can activate the prothrombotic TF pathway. "The hypercoagulable state caused by the use of recombinant human granulocyte colony-stimulating factor...

Fourth phase II trial initiated for new stem cell transplantation drug candidate.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced the initiation of its fourth phase II clinical trial to evaluate AMD3100 as a new stem cell transplantation drug candidate for cancer patients. Clinical data to date...

Immunotherapeutics company prices $52.5M public offering.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) announced that it has priced its previously announced public offering of common stock. In the offering, Antigenics is selling 5,000,000 shares at a price to the public of...

Preliminary data presented on ATL1102 phase I study.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Antisense Therapeutics, Ltd., announced that preliminary data from its phase I human clinical trials on ATL1102, Antisense Therapeutics' second generation antisense drug for multiple sclerosis (MS), was...

Results reported in phase II trial of G17DT in combination with cisplatin, 5-FU.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Aphton Corporation (APHT) announced final results from its phase II single-arm clinical trial of G17DT in combination therapy with cisplatin and 5-FU in patients with advanced gastric (stomach) cancer....

Two new real-time PCR systems detect, quantify nucleic acid sequences.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Applied Biosystems (ABI), an Applera Corporation business, announced the availability of two new real-time PCR systems for the detection and quantification of nucleic acid sequences. The Applied...

Radio frequency identification expert named to advisory board.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Applied DNA Sciences, Inc., (APDN), a provider of proprietary, DNA-embedded security applications, has appointed Richard W. Durkee to the company's board of advisors. Durkee will contribute his...

Walking 10,000 steps may require exercise.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Walking 10,000 steps to good health may be harder than it looks. Simply padding around from place to place during the day, while better than nothing, isn't enough to achieve the federal minimum target...

Biotech company reports loss of $0.22 per share.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Array BioPharma, Inc., (ARRY) reported financial results for the second quarter of fiscal 2004, ended December 31, 2003. During the second quarter of fiscal 2004, Array reported total revenue of...

New estrogen inhibitor in phase II development.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Ascend Therapeutics, Inc., announced that it has obtained exclusive North American development, marketing and commercialization rights to the developmental pharmaceutical product, TamoGel...

BIS technology to be integrated across monitoring product line.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Aspect Medical Systems, Inc., (ASPM) has entered into a multiyear, worldwide development and licensing agreement with Draeger Medical Systems, Inc., the Patient Monitoring subsidiary of Draeger Medical...

Device firm to develop immunochromatographic rapid test devices.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- AspenBio, Inc., (APNB) announced that it has created a Lateral Flow Division for the development, manufacturing and distribution of immunochromatographic rapid test devices. The devices determine...

IRESSA (gefitinib) added to ASCO practice guidelines.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- An expert panel of the American Society of Clinical Oncology (ASCO) has updated their "Clinical Practice Guidelines" for the treatment of non-small cell lung cancer (NSCLC). For the first time the...

New data suggest seroquel improves quality of life in first-episode psychosis.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- New data presented at the sixth scientific meeting of the European First Episode Schizophrenia Network show that patients suffering their first episode of psychosis benefit from significant symptom...

Gould named chief financial officer at drug delivery company.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Atrix Laboratories, Inc., (ATRX) announced the appointment of Gregory A. Gould to the position of chief financial officer. "We are pleased to welcome Greg to our management team," said David R....

Distribution agreement signed for Testim testosterone gel in Canada.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Auxilium Pharmaceuticals, Inc., and Bayer, Inc., a division of Bayer AG (BAY), announced a distribution agreement for marketing of Auxilium's Testim 1% testosterone gel in Canada. Testim has been...

Pharmaceutical company discovers prostate cancer biomarker.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Avalon Pharmaceuticals, Inc., announced the discovery of a prostate cancer biomarker in the peer-reviewed journal of the International Union Against Cancer, the International Journal of Cancer. The...

U.S. clearance granted for AxSYM BNP test.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced that its manufacturing partner, Axis-Shield, has received clearance from the U.S. Food and Drug Administration for a B-type Natriuretic Peptide (BNP) test for use on...

Analysis says states are under-funding nursing home care.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- A new analysis of the U.S. Medicaid program by the accounting firm BDO Seidman, conducted for the American Health Care Association, reveals states are under-funding seniors' nursing home care by at...

Salmonella found in sesame seed products.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Salmonella pathogens have been found in a variety of sesame-seed based products. "In the context of an international outbreak of multiresistant Salmonella typhimurium DT 104 that was correlated to...

Cenestin 0.45-mg tablets approved by FDA.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Barr Pharmaceuticals, Inc., (BRL) announced that its wholly owned subsidiary, Duramed Pharmaceuticals, Inc., received approval from the U.S. Food and Drug Administration for its supplemental New Drug...

Axeda DRM software licensed for proactive remote service.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- The Diagnostics Division of Bayer HealthCare, LLC, a member of the Bayer Group (BAY), and Axeda Systems, Inc., (XEDA), a provider of device relationship management (DRM) enterprise software and...

Promotions increase vending sales of low-fat items in teachers' lounges.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- The use of promotional materials increased the vending sales of low-fat items in teachers' lounges. "This study examined the impact of an environmental intervention in the form of promotional...

New cancer test expands tumor marker menu on immunoassay systems.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., (BEC) announced that its new GI Monitor, a test that aids in the management of pancreatic cancer, will now be available in the United States. "Incidence rates of pancreatic...

Results of phase I study of intranasal insulin reported.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Bentley Pharmaceuticals, Inc., (BNT) has successfully completed a phase I clinical trial using its proprietary intranasal insulin formulation in human volunteers. The study was conducted by a...

Collaboration to apply Systems Biology to toxicology study.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Beyond Genomics, Inc., announced that it has entered into a pilot agreement with AstraZeneca to apply its Systems Biology expertise to the area of predictive toxicology. Beyond Genomics (BG) will...

Imaging company reports revenue rises 28%.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Bio-Imaging Technologies, Inc., (BITI) announced its financial results for the fourth quarter and year ended December 31, 2003. Service revenues, which management believes is the key revenue...

Marketing agreement signed for promotion of aspergillus test.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced that it has entered into a marketing agreement...

Orphan drug designation granted by FDA for BCX-1777.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- BioCryst Pharmaceuticals, Inc., (BCRX) announced that the U.S. Food and Drug Administration (FDA) granted orphan drug status to BCX-1777, the company's purine nucleoside phosphorylase (PNP) inhibitor...

Supply agreement signed with Hepatotech for preservation solutions.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- BioLife Solutions, Inc., (BLFS) announced that it has signed a multiyear supply agreement with Pittsboro, North Carolina-based Hepatotech, Inc., a privately held manufacturer and distributor of...

Biopharmaceutical company reports net loss of $0.40 per share.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- BioMarin Pharmaceutical, Inc., (BMRN) announced financial results for its fourth quarter ended December 31, 2003. The net loss was $25.7 million ($0.40 per share) for the fourth quarter of 2003...

New dual chamber MAUI Mixer launched for microarray hybridization.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- BioMicro Systems announced the introduction of the MAUI Mixer DC, a new dual hybridization chamber specially designed to allow two independent arrays to be processed simultaneously on a single 1" x 3"...

Invitrogen announces expiration of its cash tender offer.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Invitrogen Corp. (IVGN) announced the results of the offer by its wholly owned subsidiary, Baseball Acquisition Corp., to purchase all of the outstanding shares of BioReliance Corp. (BREL) for $48.00...

CAP nanotechnology product developments reported.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- BioSante Pharmaceuticals, Inc., (BPA) announced an update on recent developments of its calcium phosphate-based nanotechnology (CAP). "To date we have made significant progress in development of...

ACOG promotes use of uterine artery embolization.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- BioSphere Medical, Inc., (BSMD) reported that on January 30, 2004, The American College of Obstetricians and Gynecologists (ACOG) released an opinion on uterine artery embolization (UAE) for the...

Milestone payment made in anticipation of NDA filing of Clofarabine.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Bioenvision, Inc., (BIV) announced that it has signed an agreement with Ilex Products, Inc., a wholly owned subsidiary of Ilex Oncology, Inc., (ILXO), in which Bioenvision has converted Ilex's option to...

FDA clears Waterlase for bone, periodontal, soft tissue indications.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Biolase Technology, Inc., (BLTI) has received clearance from the U.S. Food and Drug Administration for its patented Waterlase technology for several new bone, periodontal, and soft tissue procedures....

Nanotechnology coatings completes first round of financing.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Biophan Technologies, Inc., (BIPH) announced that it has completed its first round of financing with SBI-Brightline, Irvine, California. The financing will further enable the company to pursue its...

Deal signed with Amylin Pharmaceuticals to develop Omniclonal antibodies.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Biosite Incorporated (BSTE) has entered into a discovery collaboration with Amylin Pharmaceuticals, Inc., under which Biosite intends to develop Omniclonal antibodies for targets provided by Amylin. ...

Diabetes drug maker closes private placement funding.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Robert Rieveley, president of Biotech Holdings (BIO.V; BIOHF), said that the company has now closed $266,000 of private placements announced January 27, 2004. "These funds allow us to complete all...

Biotech industry association leader to retire at year end.
March 3, 2004... 2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Biotechnology Industry Organization (BIO) president Carl B. Feldbaum and BIO chairman Richard Pops issued the following joint statement: After more than 30 years in Washington, DC, and 11 years as...